Henryk T Dudek

This inventor holds 65 USPTO granted patents and 24 published patent applications, plus 2 CIPO patents and 9 EPO patents, primarily in RNA Therapeutics (CPC class C12N). Top assignees: Dicerna Pharmaceuticals, Inc., Novo Nordisk A/s, Curis, Inc.. Active years: 2001-2026.

USPTO Granted Patents = 65 (Patent Applications = 24)

% Patents Active = 87.7

CIPO Patents = 2 (Patent Applications = 24)

EPO Patents = 9 (Patent Applications = 33)

Average Co-Inventor Count = 2.4

ph-index = 6

Forward Citations = 226(Granted Patents)

Forward Citations (Not Self Cited) = 168(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Cambridge, MA (US) (2021)
Wellesley, MA (US) (2001 - 2024)
Lexington, MA (US) (2022 - 2024)
Belmont, MA (US) (2023 - 2024)

Company Filing History:

57 out of 102

Dicerna Pharmaceuticals, Inc.

where one patent can have more than one assignee

Years Active: 2001-2026

Loading Chart...

Areas of Expertise:

RNA Therapeutics

LDHA

Alpha-1 Antitrypsin

TMPRSS6

Transthyretin

PCSK9

Glycolate Oxidase

Complement Component 5

Lactate Dehydrogenase

APOC3

PNPLA3

GYS2

65 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12735710 - COMPOSITIONS AND METHODS FOR INHIBITING ANGPTL3 EXPRESSION (2026-09-15),

2. 12674169 - Compositions and methods for modulatingactivity (2026-07-07),

3. 12674161 - STAT3 targeting oligonucleotides and uses thereof (2026-07-07),

4. 12534730 - COMPOSITIONS AND METHODS FOR INHIBITING GYS2 EXPRESSION (2026-01-27),

5. 12503701 - COMPOSITIONS AND METHODS FOR INHIBITING TRANSMEMBRANE SERINE PROTEASE 6 (TMPRSS6) EXPRESSION (2025-12-23),

6. 12435336 - Compositions and methods for inhibiting LPA expression (2025-10-07),

7. 12252691 - Compositions and methods for inhibiting LPA expression (2025-03-18),

8. 12234456 - Compositions and methods for modulating APOC3 expression (2025-02-25),

9. 12084662 - Compositions and methods for modulating PNPLA3 expression (2024-09-10),

10. 11952574 - Compositions and methods for inhibiting transmembrane serine protease 6 (TMPRSS6) expression (2024-04-09),

11. 11912996 - Methods and compositions for the specific inhibition of alpha-1 antitrypsin by double-stranded RNA (2024-02-27),

12. 11873493 - Methods and compositions for the specific inhibition of glycolate oxidase (HAO1) by double-stranded RNA (2024-01-16),

13. 11851658 - Methods and compositions for the specific inhibition of alpha-1 antitrypsin by double-stranded RNA (2023-12-26),

14. 11773390 - Methods and compositions for the specific inhibition of Complement Component 5(C5) by double-stranded RNA (2023-10-03),

15. 11697812 - Methods and compositions for the specific inhibition of transthyretin (TTR) by double-stranded RNA (2023-07-11),

Title: Henryk T Dudek: Pioneering Inventor from Wellesstate, MA

Introduction: Henryk T Dudek is a renowned inventor hailing from Wellesley, MA, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Henryk T Dudek holds several patents in various technological domains, showcasing his versatility and ingenuity in inventing cutting-edge solutions for modern challenges.

Career Highlights: Throughout his illustrious career, Henryk T Dudek has consistently pushed the boundaries of innovation, with his inventions revolutionizing industries and improving the lives of many.

Collaborations: Henryk T Dudek has collaborated with leading tech companies, research institutions, and universities, fostering a culture of innovation and knowledge-sharing to drive progress in the field.

Conclusion: Henryk T Dudek's passion for innovation and his relentless pursuit of excellence have solidified his reputation as a trailblazing inventor, leaving a lasting impact on the world of technology.